RasmusTHoegMD

PubMed

• 2 citations
  Yttrium-90 ibritumomab tiuxetan plus ATG/TLI for allogeneic hematopoietic cell transplantation in non-Hodgkin lymphoma.
  Tamer Othman, Robert Lowsky, Carol Richman, Rasmus Hoeg, Mehrdad Abedi, Joseph Tuscano> ;Bone Marrow Transplantation. 2023 Oct 1
• 3 citations
  NCCN Guidelines® Insights: Hematopoietic Cell Transplantation, Version 3.2022.
  Ayman Saad, Alison Loren, Javier Bolaños-Meade, George Chen, Daniel Couriel, Antonio Di Stasi, Areej El-Jawahri, Hany Elmariah, Sherif Farag, Krishna Gundabolu, Jonath...> ;Journal of the National Comprehensive Cancer Network. 2023 Feb 1
• 1 citations
  Clinical experience with frontline Hyper-CVAD-based regimens, including Hyper-CVAD plus ponatinib, in patients with acute lymphoblastic leukemia treated at a comprehen...
  Tamer Othman, Benjamin N Moskoff, Gwendolyn Ho, Matthew E Tenold, Tali Azenkot, Margaret L Krackeler, Samantha C Fisch, Laura A Potter, Paul R Kaesberg, Jeanna L Welbo...> ;Leukemia Research. 2022 Aug 1
• Allogeneic hematopoietic cell transplantation using non-myeloablative ATG/TLI conditioning for lymphomas
  Tamer Othman, Benjamin N Moskoff, Naseem Esteghamat, Rasmus T. Hoeg, Aaron S. Rosenberg, Brian A. Jonas, Mehrdad Abedi, Carol M. Richman, Joseph Tuscano> ;Leukemia & Lymphoma. 2021 Sep 6
• 4 citations
  Safety and tolerability of lenalidomide maintenance in post-transplant acute myeloid leukemia and high-risk myelodysplastic syndrome.
  Brian Pham, Rasmus T. Hoeg, Rajeev Krishnan, Carol M. Richman, Joseph Tuscano, Mehrdad Abedi> ;Bone Marrow Transplantation. 2021 Sep 1
• 31 citations
  Outcomes of Adults With Relapsed/Refractory Acute Myeloid Leukemia Treated With Venetoclax Plus Hypomethylating Agents at a Comprehensive Cancer Center.
  Matthew E. Tenold, Benjamin N Moskoff, David J. Benjamin, Rasmus T. Hoeg, Aaron S. Rosenberg, Mehrdad Abedi, Joseph Tuscano, Brian A. Jonas> ;Frontiers in Oncology. 2021 Mar 11
• Retrospective Analysis of Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia Treated with FLAG at a Comprehensive Cancer Center.
  Matthew E. Tenold, Benjamin N Moskoff, Rajeev Krishnan, Aaron S. Rosenberg, Rasmus T. Hoeg, Mehrdad Abedi, Joseph Tuscano, Brian A. Jonas> ;Clinical Lymphoma, Myeloma & Leukemia. 2021 Jul 1
• 4 citations
  Phase I study of escalating doses of carfilzomib with HyperCVAD in patients with newly diagnosed acute lymphoblastic leukemia.
  Brian A. Jonas, Samantha C Fisch, Aaron S. Rosenberg, Rasmus T. Hoeg, Joseph Tuscano, Mehrdad Abedi> ;American Journal of Hematology. 2021 Apr 1
• 8 citations
  Effect of autologous hematopoietic stem cell transplant on the development of second primary malignancies in multiple myeloma patients
  Aaron S. Rosenberg, Ann Brunson, Joseph Tuscano, Brian A. Jonas, Rasmus T. Hoeg, Theodore Wun, Theresa H.M. Keegan> ;Blood Cancer Journal. 2021 Jan 7
• 2 citations
  A Phase I study of Everolimus and Bendamustine in Patients with relapsed/refractory lymphoid hematologic malignancies
  Rasmus T. Hoeg, Julian R Davis, Brian A. Jonas, Joseph Tuscano, Aaron S. Rosenberg, Mehrdad Abedi> ;Clinical Lymphoma, Myeloma & Leukemia. 2020 Feb 20
• 4 citations
  Management of neutropenic fever during a transition from traditional hematology/oncology service to hospitalist care
  Meghana Raghavendra, Rasmus T. Hoeg, Wayne A. Bottner, William A. Agger> ;WMJ. 2014 Apr 1
• 4 citations
  Measuring the impact of a restrictive transfusion guideline in patients with acute myeloid leukaemia
  Rasmus T. Hoeg, Eva Leinoe, P. Andersen, Tobias Wirenfeldt Klausen, Henrik Birgens> ;Vox Sanguinis. 2013 Jul 1
• [Complete remission of diffuse large B-cell lymphoma of the stomach after eradication of Helicobacter pylori].
  Rasmus T. Hoeg, Anne-Marie Skau, Peter Nørgaard, Per Boye Hansen> ;Ugeskrift for Laeger. 2011 Sep 26
• 19 citations
  Publication outcomes of phase II oncology clinical trials.
  Rasmus T. Hoeg, Jennifer A. Lee, Michelle A. Mathiason, Kristina Rokkones, Stephanie L. Serck, Kaye L. Crampton, Ann E. Emmel, Eileen A. Severson, Ronald S. Go> ;American Journal of Clinical Oncology. 2009 Jun 1
• Join now to see all

Abstracts/Posters

• Phase I Study of Escalating Doses of Carfilzomib with Hyper-CVAD in Patients with Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma
  Rasmus T Hoeg, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019